Cargando…

Construction and Antiapoptosis Activities of Recombinant Adenoviral Expression Vector Carrying EBV Latent Membrane Protein 2A

To evaluate the possible effects of LMP2A (EBV latent membrane protein 2A) on human gastric cancer cell line SGC-7901, LMP2A coding gene was subcloned into shuttle plasmid pAdTrackCMV to form transfer plasmid pAdTrackCMV-2A, which was linearized with PmeI and cotransformed into E.coli BJ5183 with ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xishuang, Gao, Yu, Luo, Bing, Zhao, Youan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157153/ https://www.ncbi.nlm.nih.gov/pubmed/21860618 http://dx.doi.org/10.1155/2011/182832

Ejemplares similares

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro
por: Gribova, I.Yu., et al.
Publicado: (2011)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

Cationic Liposome Conjugation to Recombinant Adenoviral Vector Reduces Viral Antigenicity
por: Natsume, Atsushi, et al.
Publicado: (2000)

Establishment of Epstein–Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1
por: Kanno, Hiroyuki, et al.
Publicado: (2023)

Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies
por: Zhang, Chaoting, et al.
Publicado: (2021)

Stability of a Recombinant Adenoviral Vector: Optimization of Conditions for Storage, Transport and Delivery
por: Ugai, Hideyo, et al.
Publicado: (2002)

Construction and characterization of an adenoviral vector encoding human bone morphogenetic protein-2
por: Peng, Liangquan, et al.
Publicado: (2020)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
por: Wang, Meirong, et al.
Publicado: (2021)

A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression
por: Chen, Hao, et al.
Publicado: (2015)

A Novel and Simple Method for Rapid Generation of Recombinant Porcine Adenoviral Vectors for Transgene Expression
por: Zhang, Peng, et al.
Publicado: (2015)

Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector
por: Vermeij, J, et al.
Publicado: (2001)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
por: Gao, Jian, et al.
Publicado: (2020)

Modification of Cɛ mRNA Expression by EBV-Encoded Latent Membrane Protein 1
por: Hanashiro, Kazuhiko, et al.
Publicado: (2006)

Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013)

The Role of Chromatin in Adenoviral Vector Function
por: Wong, Carmen M., et al.
Publicado: (2013)

Use of adenoviral vectors as veterinary vaccines
por: Ferreira, T B, et al.
Publicado: (2005)

Immunology of Adenoviral Vectors in Cancer Therapy
por: Shaw, Amanda Rosewell, et al.
Publicado: (2019)

Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016)

Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia
por: Qin, Yanhua, et al.
Publicado: (2018)

Loliolide Presents Antiapoptosis and Antiscratching Effects in Human Keratinocytes
por: Park, Sang Hee, et al.
Publicado: (2019)

A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect
por: Liu, Xin-Ran, et al.
Publicado: (2012)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
por: Zhang, Jianfeng
Publicado: (2012)

Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs
por: Alonso-Padilla, Julio, et al.
Publicado: (2016)

A Novel Adenoviral Hybrid-vector System Carrying a Plasmid Replicon for Safe and Efficient Cell and Gene Therapeutic Applications
por: Voigtlander, Richard, et al.
Publicado: (2013)

Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies
por: Mao, Yuan, et al.
Publicado: (2013)

Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis
por: Zhang, Yongfeng, et al.
Publicado: (2018)

Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis
por: Hu, Xinyu, et al.
Publicado: (2018)

Using Multivalent Adenoviral Vectors for HIV Vaccination
por: Gu, Linlin, et al.
Publicado: (2013)

An Adenoviral Vector Based Vaccine for Rhodococcus equi
por: Giles, Carla, et al.
Publicado: (2016)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors
por: Iampietro, M. Justin, et al.
Publicado: (2018)

Targeted Adenoviral Vectors I: Transductional Targeting
por: Dmitriev, Igor P., et al.
Publicado: (2016)

Engineering Adenoviral Vectors with Improved GBM Selectivity
por: Bates, Emily A., et al.
Publicado: (2023)

CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC
por: Wang, Weiwen, et al.
Publicado: (2020)

Establishment of a Parvovirus B19 NS1-Expressing Recombinant Adenoviral Vector for Killing Megakaryocytic Leukemia Cells
por: Xu, Peng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2r9kcb8ge2relcid6fb54dpptb